Search research articles
Contact Us
Filters
Showing results (201-210 of 267) with videos related to
Page
of 27
Sort By:
Journal of Medical Virology
|
October 14, 2024
Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories
Valentine Marie Ferré, Romain Coppée, Fifonsi A Gbeasor-Komlanvi, et al.
The Journal of Antimicrobial Chemotherapy
|
September 17, 2021
Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients
Charlotte Charpentier, Alexandre Storto, Cathia Soulié, et al.
Antimicrobial Agents and Chemotherapy
|
August 19, 2015
Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study
Elodie Valade, Jean-Marc Tréluyer, Silvia M Illamola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2014
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens
Jade Ghosn, Marianne Leruez-Ville, Jérôme Blanche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 12, 2025
HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an Update
Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2024
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing Regimen
Thomas Montrouge, Mélanie Bertine, Gilles Peytavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 14, 2021
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton, Marine Livrozet, Delphine Planas, et al.
Annals of Internal Medicine
|
June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial
Matthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Communications Medicine
|
January 27, 2026
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
Gilbert Mchantaf, Adeline Melard, Kévin Da Silva, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 267) with videos related to
Sort By:
Page
of 27
Journal of Medical Virology
|
October 14, 2024
Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories
Valentine Marie Ferré, Romain Coppée, Fifonsi A Gbeasor-Komlanvi, et al.
The Journal of Antimicrobial Chemotherapy
|
September 17, 2021
Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients
Charlotte Charpentier, Alexandre Storto, Cathia Soulié, et al.
Antimicrobial Agents and Chemotherapy
|
August 19, 2015
Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study
Elodie Valade, Jean-Marc Tréluyer, Silvia M Illamola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2014
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens
Jade Ghosn, Marianne Leruez-Ville, Jérôme Blanche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 12, 2025
HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an Update
Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2024
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing Regimen
Thomas Montrouge, Mélanie Bertine, Gilles Peytavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 14, 2021
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton, Marine Livrozet, Delphine Planas, et al.
Annals of Internal Medicine
|
June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial
Matthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Communications Medicine
|
January 27, 2026
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
Gilbert Mchantaf, Adeline Melard, Kévin Da Silva, et al.
Page
of 27